In this issue:
- TAF to TDF switch improves lipids and protects from weight gain
- Treatment of anal HSILs to prevent anal cancer
- Long-term effectiveness of rilpivirine-based single-tablet regimens
- Sexual behaviours and STIs after PrEP initiation in MSM
- Telomere length declines before ART initiation, not after viral suppression
- Asymptomatic Mycoplasma genitalium infections among MSM
- Delayed HIV diagnosis among Auckland/Northland women
- Physical and psychiatric comorbidities among ART initiators
- Post partum follow-up of dolutegravir vs. efavirenz initiated in late pregnancy
- Syphilis reinfection in men living with HIV
- Dolutegravir or darunavir, plus lamivudine with zidovudine or tenofovir, as second-line HIV treatment
- Severe/fatal COVID-19 in hospitalised patients with HIV
Please login below to download this issue (PDF)